Unknown

Dataset Information

0

Synthesis and biological evaluation of phenanthrenes as cytotoxic agents with pharmacophore modeling and ChemGPS-NP prediction as topo II inhibitors.


ABSTRACT: In a structure-activity relationship (SAR) study, 3-methoxy-1,4-phenanthrenequinones, calanquinone A (6a), denbinobin (6b), 5-OAc-calanquinone A (7a) and 5-OAc-denbinobin (7b), have significantly promising cytotoxicity against various human cancer cell lines (IC(50) 0.08-1.66 µg/mL). Moreover, we also established a superior pharmacophore model for cytotoxicity (r = 0.931) containing three hydrogen bond acceptors (HBA1, HBA2 and HBA3) and one hydrophobic feature (HYD) against MCF-7 breast cancer cell line. The pharmacophore model indicates that HBA3 is an essential feature for the oxygen atom of 5-OH in 6a-b and for the carbonyl group of 5-OCOCH(3) in 7a-b, important for their cytotoxic properties. The SAR for moderately active 5a-b (5-OCH(3)), and highly active 6a-b and 7a-b, are also elaborated in a spatial aspect model. Further rational design and synthesis of new cytotoxic phenanthrene analogs can be implemented via this model. Additionally, employing a ChemGPS-NP based model for cytotoxicity mode of action (MOA) provides support for a preliminary classification of compounds 6a-b as topoisomerase II inhibitors.

SUBMITTER: Lee CL 

PROVIDER: S-EPMC3362575 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and biological evaluation of phenanthrenes as cytotoxic agents with pharmacophore modeling and ChemGPS-NP prediction as topo II inhibitors.

Lee Chia-Lin CL   Lin Ying-Ting YT   Chang Fang-Rong FR   Chen Guan-Yu GY   Backlund Anders A   Yang Juan-Chang JC   Chen Shu-Li SL   Wu Yang-Chang YC  

PloS one 20120529 5


In a structure-activity relationship (SAR) study, 3-methoxy-1,4-phenanthrenequinones, calanquinone A (6a), denbinobin (6b), 5-OAc-calanquinone A (7a) and 5-OAc-denbinobin (7b), have significantly promising cytotoxicity against various human cancer cell lines (IC(50) 0.08-1.66 µg/mL). Moreover, we also established a superior pharmacophore model for cytotoxicity (r = 0.931) containing three hydrogen bond acceptors (HBA1, HBA2 and HBA3) and one hydrophobic feature (HYD) against MCF-7 breast cancer  ...[more]

Similar Datasets

| S-EPMC6214110 | biostudies-literature
| S-EPMC6314802 | biostudies-literature
| S-EPMC7487730 | biostudies-literature
| S-EPMC4088285 | biostudies-literature
| S-EPMC6272247 | biostudies-literature
| S-EPMC3257097 | biostudies-literature
| S-EPMC4103762 | biostudies-literature
| S-EPMC5769857 | biostudies-literature
| S-EPMC3780516 | biostudies-literature
| S-EPMC6083788 | biostudies-literature